Lipid Peroxidation
Description
Lipid peroxidation is the oxidative degradation of polyunsaturated fatty acids (PUFAs) in cellular membranes, producing reactive lipid aldehydes -- primarily 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA) -- that covalently modify proteins, disrupt membrane integrity, and propagate oxidative damage. The process can occur non-enzymatically via iron-catalyzed Fenton chemistry or enzymatically via 12/15-lipoxygenase (12/15-LOX) acting on arachidonic acid. The brain is exquisitely vulnerable due to its high PUFA content (particularly DHA and arachidonic acid in synaptic membranes), abundant redox-active iron, and high oxygen consumption.
In Alzheimer's disease, lipid peroxidation serves as a critical mechanistic bridge between oxidative stress and autophagic collapse. The key discovery is that 4-HNE -- the primary toxic aldehyde from PUFA peroxidation -- covalently modifies and inhibits the v-ATPase proton pump on lysosomal membranes. This directly connects membrane oxidative damage to the lysosomal acidification failure that underlies the Convergent Autophagic Collapse. GPX4, the selenoprotein enzyme that neutralizes lipid hydroperoxides, is depleted in AD brains. FAD-associated presenilin mutations impair GPX4 expression via a Notch-LRP8-Selenoprotein P axis, creating a genetic link between presenilin biology and lipid peroxidation vulnerability.
APOE4 amplifies lipid peroxidation through its structural loss of a disulfide bridge present in APOE2/E3, leaving its PUFA cargo unprotected during transport. This positions lipid peroxidation at the intersection of the ferroptosis pathway, the ApoE4 risk mechanism, and the lysosomal acidification failure that constitutes the terminal AD phenotype. Amyloid plaques may initially function as sinks that sequester 4-HNE and other toxic lipid aldehydes.
Convergence Nodes
- Endosomal Nexus -- 4-HNE from lipid peroxidation disrupts ApoE-ApoER2-Dab1 receptor trafficking
- APOE4 Hub -- APOE4 loss of disulfide bridge creates unprotected PUFA cargo vulnerable to peroxidation
- Compensatory Paradigm Nexus -- Abeta may function as antioxidant response to lipid peroxidation products
Prize Entrants
- Pamela Maher -- Identified the complete biochemical pathway from GSH depletion through GPX4 inactivation, 12/15-LOX activation, 4-HNE generation, to v-ATPase poisoning; developed anti-ferroptotic drug candidates targeting this cascade
- Ashley Bush -- Linked age-dependent iron accumulation to Fenton chemistry-driven lipid peroxidation; identified PSEN1-Notch-LRP8-GPX4 axis; proposed amyloid plaques as lipid aldehyde sinks
External Scientists
- Brent Stockwell -- Defined ferroptosis linking lipid peroxidation to regulated cell death
- Scott Ayton -- Brain iron quantification and its relationship to lipid peroxidation
- Norman Haughey -- Lipid biomarkers including peroxidation products in AD
Key Open Questions
- Is 4-HNE modification of v-ATPase the primary or a contributory mechanism of lysosomal acidification failure?
- Can lipid peroxidation biomarkers (F2-isoprostanes, 4-HNE adducts) serve as preclinical AD markers for patient stratification?
- Does dietary PUFA composition (omega-3 vs omega-6 ratio) modulate AD risk through differential peroxidation susceptibility?
- How does APOE genotype-dependent PUFA protection interact with brain iron levels to determine individual ferroptotic vulnerability?
kb/wiki/concepts/lipid-peroxidation.md